Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)
7.20
-0.05 (-0.69%)
Sep 15, 2026, 1:20 PM CST
TPEX:4186 Market Cap
TPEX:4186 has a market cap or net worth of 822.6 million as of September 15, 2026. Its market cap has decreased by -36.31% in one year.
Market Cap
822.60M
Enterprise Value
958.86M
Revenue
348.54M
Ranking
n/a
PE Ratio
52.70
Stock Price
7.20
ChartMarket Cap Chart
Since November 27, 2012, TPEX:4186's market cap has decreased from 4.10B to 822.60M, a decrease of -79.92%. That is a compound annual growth rate of -10.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 396.00M | -60.54% |
| Dec 31, 2025 | 1.00B | -29.21% |
| Dec 31, 2024 | 1.42B | -4.55% |
| Dec 29, 2023 | 1.49B | -6.78% |
| Dec 30, 2022 | 1.59B | -4.84% |
| Dec 30, 2021 | 1.67B | -26.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeneReach Biotechnology | 926.79M |
| NatureWise Biotech & Medicals | 867.37M |
| Meribank Biotech | 834.03M |
| Neith | 793.51M |
| Lukas Biomedical | 766.30M |
| BioLASCO Taiwan | 729.94M |
| MegaPro Biomedical | 711.93M |
| SynCore Biotechnology Co.,Ltd | 641.76M |